GeneDx Holdings Corp. (WGS) Stock Overview
Explore GeneDx Holdings Corp.’s financial performance, market position, analyst ratings, and future outlook.
GeneDx Holdings Corp. (WGS)
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
-21.28
EPS (TTM)
$-2.66
ROE
-0.28%
WGS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of GeneDx Holdings Corp. (WGS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 59.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.10.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.28 and a market capitalization of 1.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.